In his written statement, Professor Makris cited two studies demonstrating persisting liver damage in those who had been infected through blood products and successfully cleared Hepatitis C. Read more about In his written statement, Professor Makris cited two studies demonstrating persisting liver damage in those who had been infected through blood products and successfully cleared Hepatitis C.
In his written statement, Professor Makris recommended that patients with an inherited bleeding disorder who have cleared Hepatitis C should be seen by a consultant hepatologist and have blood tests, an ultrasound scan and a fibroscan. Read more about In his written statement, Professor Makris recommended that patients with an inherited bleeding disorder who have cleared Hepatitis C should be seen by a consultant hepatologist and have blood tests, an ultrasound scan and a fibroscan.
In his written statement, Professor Makris recommended that patients with an inherited bleeding disorder infected with Hepatitis C, including those who had successfully cleared the virus, should be reviewed by a liver specialist at least once. Read more about In his written statement, Professor Makris recommended that patients with an inherited bleeding disorder infected with Hepatitis C, including those who had successfully cleared the virus, should be reviewed by a liver specialist at least once.
In his statement, Professor Chris Jones stated that an oversight group had been set up by the Welsh Government to oversee the elimination of Hepatitis across the 7 Welsh health boards through public awareness and improved access to testing. Read more about In his statement, Professor Chris Jones stated that an oversight group had been set up by the Welsh Government to oversee the elimination of Hepatitis across the 7 Welsh health boards through public awareness and improved access to testing.
Monitoring of patients in Wales is dependent on the nature of the damage done by Hepatitis C prior to treatment. Professor Jones explained that patients are discharged if there is minimal liver damage, whereas those with advanced liver disease will be monitored by a hepatology clinic, including having regular scans. Read more about Monitoring of patients in Wales is dependent on the nature of the damage done by Hepatitis C prior to treatment. Professor Jones explained that patients are discharged if there is minimal liver damage, whereas those with advanced liver disease will be monitored by a hepatology clinic, including having regular scans.
Professor Chris Jones stated in his written evidence that in Wales there are currently no restrictions on treatment for Hepatitis C and currently no waiting lists for treatment. Read more about Professor Chris Jones stated in his written evidence that in Wales there are currently no restrictions on treatment for Hepatitis C and currently no waiting lists for treatment.
Professor Chris Jones, DCMO, told the Inquiry: "The Welsh Government allocated additional resources to health boards for the new antiviral medications in 2015/16. Funding was allocated in line with anticipated health board treatment demand and there was no cap put on the number of patients that could be treated within any health board." Read more about Professor Chris Jones, DCMO, told the Inquiry: "The Welsh Government allocated additional resources to health boards for the new antiviral medications in 2015/16. Funding was allocated in line with anticipated health board treatment demand and there was no cap put on the number of patients that could be treated within any health board."
In response to Professor Makris' concerns regarding patients who may have undergone Hepatitis C treatment solely directed by haemophilia centres, Dr Stephen Barclay stated that he had confirmed this practice did not take place in Scotland. Read more about In response to Professor Makris' concerns regarding patients who may have undergone Hepatitis C treatment solely directed by haemophilia centres, Dr Stephen Barclay stated that he had confirmed this practice did not take place in Scotland.
In his written evidence, Dr Stephen Barclay noted that almost 90% of those infected with Hepatitis C in Scotland been identified and the majority of those had received treatment. Read more about In his written evidence, Dr Stephen Barclay noted that almost 90% of those infected with Hepatitis C in Scotland been identified and the majority of those had received treatment.
Professor John Dillon stated in his written statement that "All patients in Scotland have access to treatment with a direct acting antiviral regimen, irrespective of stage of disease or route of infection" and that no waiting lists for treatment exist in Scotland. Read more about Professor John Dillon stated in his written statement that "All patients in Scotland have access to treatment with a direct acting antiviral regimen, irrespective of stage of disease or route of infection" and that no waiting lists for treatment exist in Scotland.